CTS OpTmizer One SFM offers enhanced T cell expansion and high viability while maintaining early memory cell phenotype
CTS OpTmizer One SFM supported more consistent enhanced T cell expansion, while maintaining high cell viability, early memory cell phenotype, and CD4:CD8 ratios with healthy and diseased AML and CLL donor cells
Thank You For Your Interest
You have been directed to this site by DemandBytes. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.
This website or its third-party tools process personal data.In case of sale of your personal information, you may opt out by using the link Do not sell my personal information.
Our sites use tools, such as cookies, to understand how you use our services and to improve both your experience and our advertising relevance. Here, you can opt-out of such tracking.